North Star Investment Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$62.3K Hold
600
﹤0.01% 683
2025
Q4
$62.7K Hold
600
﹤0.01% 624
2025
Q3
$55.5K Hold
600
﹤0.01% 636
2025
Q2
$47.9K Hold
600
﹤0.01% 642
2025
Q1
$52K Hold
600
﹤0.01% 605
2024
Q4
$49.6K Hold
600
﹤0.01% 615
2024
Q3
$52.2K Hold
600
﹤0.01% 589
2024
Q2
$49.3K Hold
600
﹤0.01% 599
2024
Q1
$48.1K Hold
600
﹤0.01% 616
2023
Q4
$45.7K Hold
600
﹤0.01% 603
2023
Q3
$43.4K Hold
600
﹤0.01% 611
2023
Q2
$45.4K Hold
600
﹤0.01% 623
2023
Q1
$45.6K Hold
600
﹤0.01% 633
2022
Q4
$47.2K Hold
600
﹤0.01% 605
2022
Q3
$43K Hold
600
﹤0.01% 571
2022
Q2
$45K Hold
600
﹤0.01% 563
2022
Q1
$48K Hold
600
﹤0.01% 587
2021
Q4
$49K Hold
600
﹤0.01% 613
2021
Q3
$46K Hold
600
﹤0.01% 605
2021
Q2
$48K Hold
600
﹤0.01% 590
2021
Q1
$47K Hold
600
﹤0.01% 561
2020
Q4
$43K Hold
600
﹤0.01% 557
2020
Q3
$38K Hold
600
﹤0.01% 555
2020
Q2
$39K Hold
600
0.01% 529
2020
Q1
$33K Hold
600
﹤0.01% 558
2019
Q4
$39K Buy
+600
New +$36.5K ﹤0.01% 598

Other funds holding PJP

North Star Investment Management's PJP Position: Q1 2026 in Review

North Star Investment Management held its Invesco Pharmaceuticals ETF (PJP) position steady in Q1 2026 at 600 shares worth $62.3K. The position accounts for ﹤0.01% of the portfolio, ranked #683.

North Star Investment Management first reported a position in PJP in Q4 2019 and has held it in 26 quarters since. The position peaked at $62.7K in Q4 2025. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

  • North Star Investment Management held 600 shares of Invesco Pharmaceuticals ETF worth $62.3K as of Q1 2026.
  • North Star Investment Management left its Invesco Pharmaceuticals ETF share count unchanged in Q1 2026.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of North Star Investment Management's portfolio in Q1 2026, its #683 holding.
  • North Star Investment Management first reported a position in Invesco Pharmaceuticals ETF in Q4 2019 and has held it in 26 quarters since.
  • North Star Investment Management's Invesco Pharmaceuticals ETF position peaked at $62.7K in Q4 2025.
  • 119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.